BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21554743)

  • 1. Selection of drug resistant mutants from random library of Plasmodium falciparum dihydrofolate reductase in Plasmodium berghei model.
    Tipsuwan W; Srichairatanakool S; Kamchonwongpaisan S; Yuthavong Y; Uthaipibull C
    Malar J; 2011 May; 10():119. PubMed ID: 21554743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selectable marker human dihydrofolate reductase enables sequential genetic manipulation of the Plasmodium berghei genome.
    de Koning-Ward TF; Fidock DA; Thathy V; Menard R; van Spaendonk RM; Waters AP; Janse CJ
    Mol Biochem Parasitol; 2000 Mar; 106(2):199-212. PubMed ID: 10699250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic Plasmodium parasites stably expressing Plasmodium vivax dihydrofolate reductase-thymidylate synthase as in vitro and in vivo models for antifolate screening.
    Somsak V; Uthaipibull C; Prommana P; Srichairatanakool S; Yuthavong Y; Kamchonwongpaisan S
    Malar J; 2011 Oct; 10():291. PubMed ID: 21981896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying antimalarial compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling.
    Aroonsri A; Akinola O; Posayapisit N; Songsungthong W; Uthaipibull C; Kamchonwongpaisan S; Gbotosho GO; Yuthavong Y; Shaw PJ
    Int J Parasitol; 2016 Jul; 46(8):527-35. PubMed ID: 27150044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase.
    Sirawaraporn W; Sathitkul T; Sirawaraporn R; Yuthavong Y; Santi DV
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1124-9. PubMed ID: 9037017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
    Madkhali AM; Al-Mekhlafi HM; Atroosh WM; Ghzwani AH; Zain KA; Abdulhaq AA; Ghailan KY; Anwar AA; Eisa ZM
    Malar J; 2020 Dec; 19(1):446. PubMed ID: 33267841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular surveillance of anti-malarial resistance Pfdhfr and Pfdhps polymorphisms in African and Southeast Asia Plasmodium falciparum imported parasites to Wuhan, China.
    Jiang T; Cheng W; Yao Y; Tan H; Wu K; Li J
    Malar J; 2020 Nov; 19(1):434. PubMed ID: 33238987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
    Basco LK; Ringwald P
    Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of genetic hitchhiking around dihydrofolate reductase gene associated with pyrimethamine resistance in Plasmodium falciparum isolates from India.
    Lumb V; Das MK; Singh N; Dev V; Wajihullah ; Sharma YD
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5173-80. PubMed ID: 19786603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
    Jiang T; Chen J; Fu H; Wu K; Yao Y; Eyi JUM; Matesa RA; Obono MMO; Du W; Tan H; Lin M; Li J
    Malar J; 2019 Mar; 18(1):101. PubMed ID: 30914041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disagreement in genotyping results of drug resistance alleles of the Plasmodium falciparum dihydrofolate reductase (Pfdhfr) gene by allele-specific PCR (ASPCR) assays and Sanger sequencing.
    Sharma D; Lather M; Dykes CL; Dang AS; Adak T; Singh OP
    Parasitol Res; 2016 Jan; 115(1):323-8. PubMed ID: 26407876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA; Mahdy MA; Lim YA
    Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium falciparum strains harboring dihydrofolate reductase with the I164L mutation are absent in Malawi and Zambia even under antifolate drug pressure.
    Ochong E; Bell DJ; Johnson DJ; D'Alessandro U; Mulenga M; Muangnoicharoen S; Van Geertruyden JP; Winstanley PA; Bray PG; Ward SA; Owen A
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3883-8. PubMed ID: 18725445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
    Yaqoob A; Khattak AA; Nadeem MF; Fatima H; Mbambo G; Ouattara A; Adams M; Zeeshan N; Takala-Harrison S
    Malar J; 2018 Dec; 17(1):471. PubMed ID: 30558587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The F423Y mutation in the pfmdr2 gene and mutations N51I, C59R, and S108N in the pfdhfr gene are independently associated with pyrimethamine resistance in Plasmodium falciparum isolates.
    Briolant S; Bogreau H; Gil M; Bouchiba H; Baret E; Amalvict R; Rogier C; Pradines B
    Antimicrob Agents Chemother; 2012 May; 56(5):2750-2. PubMed ID: 22314533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
    Sitali L; Mwenda MC; Miller JM; Bridges DJ; Hawela MB; Hamainza B; Mudenda-Chilufya M; Chizema-Kawesha E; Daniels RF; Eisele TP; Nerland AH; Chipeta J; Lindtjorn B
    Acta Trop; 2020 Dec; 212():105704. PubMed ID: 33002448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escalating Plasmodium falciparum antifolate drug resistance mutations in Macha, rural Zambia.
    Mkulama MA; Chishimba S; Sikalima J; Rouse P; Thuma PE; Mharakurwa S
    Malar J; 2008 May; 7():87. PubMed ID: 18495008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conflicting requirements of Plasmodium falciparum dihydrofolate reductase mutations conferring resistance to pyrimethamine-WR99210 combination.
    Japrung D; Leartsakulpanich U; Chusacultanachai S; Yuthavong Y
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4356-60. PubMed ID: 17875995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
    Kaingona-Daniel EP; Gomes LR; Gama BE; Almeida-de-Oliveira NK; Fortes F; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Malar J; 2016 Jun; 15():309. PubMed ID: 27267365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antifolate resistant mutations of Plasmodium falciparum dihydrofolate reductase selected in Escherichia coli.
    Chusacultanachai S; Thiensathit P; Tarnchompoo B; Sirawaraporn W; Yuthavong Y
    Mol Biochem Parasitol; 2002 Mar; 120(1):61-72. PubMed ID: 11849706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.